Cell Growth & Differentiation, Vol 6, Issue 1 51-57, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1

LF Joseph, S Ezhevsky and DW Scott
Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, New York 14642.

The product of the retinoblastoma gene, RB-1, is the prototype of a class of tumor suppressor genes that is expressed in most mammalian cells. The RB protein is phosphorylated in a cell cycle-dependent manner and is modulated during cellular differentiation. We have shown previously that anti-immunoglobulin M (anti-mu) treatment of WEHI-231 and CH31 B-lymphoma cells caused cell cycle blockade and apoptosis. In such arrested cells, pRB was predominantly in the underphosphorylated (active) form, in contrast to hyperphosphorylated pRB in control log phase cells. Herein we examine the modulation of pRB phosphorylation by anti-mu and its effect on a cyclin:kinase complex that can act on pRB in murine B-lymphoma cells. In unsynchronized B-lymphoma cells, anti-mu cross-linking of membrane immunoglobulin M leads to an accumulation of the hypophosphorylated form of pRB, a decrease in the abundance of one form of cyclin A, and inhibition of cyclin A and cdk2-associated kinase activity. Using centrifugal elutriation, we also show that anti-mu treatment prevents the phosphorylation of the retinoblastoma gene product only when added in early G1. In addition, there is a critical point after which membrane immunoglobulin M cross-linking is no longer effective at preventing this process. We suggest that anti-mu-mediated growth arrest is due to the direct or indirect inactivation of an active kinase complex capable of pRB phosphorylation.

This article has been cited by other articles:

				P. Mallikaratchy, Z. Tang, S. Kwame, L. Meng, D. Shangguan, and W. Tan Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells Mol. Cell. Proteomics, December 1, 2007; 6(12): 2230 - 2238. [Abstract] [Full Text] [PDF]

				O. Adegbola and G. R. Pasternack Phosphorylated Retinoblastoma Protein Complexes with pp32 and Inhibits pp32-mediated Apoptosis J. Biol. Chem., April 22, 2005; 280(16): 15497 - 15502. [Abstract] [Full Text] [PDF]

				D. Donjerkovic, L. Zhang, and D. W. Scott Regulation of p27Kip1 Accumulation in Murine B-Lymphoma Cells: Role of c-Myc and Calcium Cell Growth Differ., October 1, 1999; 10(10): 695 - 704. [Abstract] [Full Text]

				R. Marches, R. Hsueh, and J. W. Uhr Cancer dormancy and cell signaling: Induction of p21waf1 initiated by membrane IgM engagement increases survival of B lymphoma cells PNAS, July 20, 1999; 96(15): 8711 - 8715. [Abstract] [Full Text] [PDF]

				A. BRÁS, A. RUIZ-VELA, G. GONZÁLEZ DE BUITRAGO, and C. MARTÍNEZ-A Caspase activation by BCR cross-linking in immature B cells: differential effects on growth arrest and apoptosis FASEB J, May 1, 1999; 13(8): 931 - 944. [Abstract] [Full Text]

				E. W.-F. Lam, M. S. K. Choi, J. van der Sman, S. A. Burbidge, and G. G. B. Klaus Modulation of E2F Activity via Signaling through Surface IgM and CD40 Receptors in WEHI-231 B Lymphoma Cells J. Biol. Chem., April 17, 1998; 273(16): 10051 - 10057. [Abstract] [Full Text] [PDF]

				E. S. Vitetta, T. F. Tucker, E. Racila, Y.-W. Huang, R. Marches, N. Lane, R. H. Scheuermann, N. E. Street, T. Watanabe, and J. W. Uhr Tumor Dormancy and Cell Signaling. V. Regrowth of the BCL1 Tumor After Dormancy Is Established Blood, June 15, 1997; 89(12): 4425 - 4436. [Abstract] [Full Text] [PDF]

				M. C. Horne, K. L. Donaldson, G. L. Goolsby, D. Tran, M. Mulheisen, J. W. Hell, and A. F. Wahl Cyclin G2 Is Up-regulated during Growth Inhibition and B Cell Antigen Receptor-mediated Cell Cycle Arrest J. Biol. Chem., May 9, 1997; 272(19): 12650 - 12661. [Abstract] [Full Text] [PDF]

				S. Patil, G. M. Wildey, T. L. Brown, L. Choy, R. Derynck, and P. H. Howe Smad7 Is Induced by CD40 and Protects WEHI 231 B-lymphocytes from Transforming Growth Factor-beta -induced Growth Inhibition and Apoptosis J. Biol. Chem., December 1, 2000; 275(49): 38363 - 38370. [Abstract] [Full Text] [PDF]